Combination therapy for inflammatory bowel disease

Gastroenterology and Hepatology

Volumn 13, Issue 5, 2017, Pages 296-298

  Hanauer, Stephen B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; BIOLOGICAL PRODUCT; CERTOLIZUMAB PEGOL; CORTICOSTEROID; GOLIMUMAB; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; NATALIZUMAB; USTEKINUMAB; VEDOLIZUMAB;

ALGORITHM; ANUS DISEASE; CLINICAL RESEARCH; CROHN DISEASE; DRUG FATALITY; DRUG SAFETY; DRUG TREATMENT FAILURE; GASTROENTEROLOGIST; HOSPITALIZATION; HUMAN; INFECTION; INFLAMMATORY BOWEL DISEASE; MAINTENANCE THERAPY; NOTE; PERIANAL DISEASE; SIDE EFFECT; TREATMENT INDICATION;

EID: 85020206226     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Colombel JF, Jharap B, Sandborn WJ, et al. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. Aliment Pharmacol Ther. 2017;45(1):50-62.
2. Colombel JF, Reinisch W, Mantzaris GJ, et al. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease-A SONIC post hoc analysis. Aliment Pharmacol Ther. 2015;41(8): 734-746.
3. Dulai PS, Siegel CA, Colombel JF, Sandborn WJ, Peyrin-Biroulet L. Systematic review: monotherapy with antitumour necrosis factor agents versus combination therapy with an immunosuppressive for IBD. Gut. 2014;63(12):1843-1853.
4. Jones JL, Kaplan GG, Peyrin-Biroulet L, et al. Effects of concomitant immunomodulator therapy on efficacy and safety of anti-Tumor necrosis factor therapy for Crohn's disease: A meta-Analysis of placebo-controlled trials. Clin Gastroenterol Hepatol. 2015;13(13):2233-2240.e1-e2; quiz e177-e178.
5. Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J. Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease. Gastroenterology. 2015;149(7):1716- 1730.